Havana, May 17 (RHC-PL)-- Cuba has created a medicine that seeks to delay the progress of Alzheimer's, according to health officials in Havana. Researchers announced that the drug, called NeuroEpo, will undergo clinical trials for the first time in humans.
The specialists seek to delay the progress of Alzheimer's and in this way improve the quality of life of people suffering from this degenerative disease through a more effective treatment with NeuroEpo, a 100% Cuban product developed by the Center for Molecular Immunology (CIM).
The drug has been shown to have a neuro-protective effect during experimental phases. This would be the first time it will been tested in humans, so the exact results in each of the patients is not known, noted Leslie Perez, a CIM researcher.
Alzheimer's is a neuro-degenerative disease that has no cure, so the specialist emphasized that the goal of treatment "is to help delay that degenerative process and improve the quality of life of that person, and the family."
According to the prevalence rates of researchers in Cuba, there are approximately 160,000 people suffering from the disease and it is estimated that by 2040 these will increase 2.3 times reaching 2.7% of the total population of the island.
Cuba Creates Medicine to Counteract Alzheimer's
![](https://www.radiohc.cu/articles/4352-alzheimer.jpeg)
Matérias relacionadas
Comentários
Deixe um comentário
Todos os campos são requeridosMais vistas
- Ministro das Relações Exteriores de Cuba denuncia que Israel está obstruindo a ajuda humanitária à Palestina
- Conselho de Ministros aprova o Programa do Governo para corrigir distorções e relançar a economia em 2025
- Ministro das Relações Exteriores rejeita novas medidas dos EUA contra Cuba
- Academia de Ciências de Cuba concede reconhecimento a Frei Betto
- Sheinbaum analisa progresso do Plano México